Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind vehicle-controlled trial of INM-755 cream in epidermolysis bullosa
MOH_2021-08-31_010170Phase 2Not yet recruiting
- Sponsor
- InMed Pharmaceuticals Inc.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabinol topical in epidermolysis bullosa (EB), sponsored by InMed Pharmaceuticals Inc. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
cannabinol topical
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on MOH_2021-08-31_010170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-08-31_010170.